AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
TENELIGLIPTIN
5 registrations across 3 African markets— 4 active
Markets with TENELIGLIPTIN
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| TENGLYN TABLETS | 🇷🇼Rwanda | ZYDUS LIFESCIENCES LIMITED | active | May 2030 |
| TILYPTIN_20 20MG TABLET TABLET | 🇲🇼Malawi | — | expired | Mar 2025 |
| AVEZA Oral tablet | 🇹🇿Tanzania | M.J Biopharm Private Limuted | active | — |
| Tiban Tablets | 🇹🇿Tanzania | Ajanta Pharma Limited | active | — |
| Tilyptin Tablets | 🇹🇿Tanzania | Micro Labs Limited | active | — |
TENELIGLIPTIN in Africa — Regulatory Overview
TENELIGLIPTIN is registered across 3 African markets with 5 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Tanzania, Malawi, Rwanda. AfricaRegulatory refreshes this data daily from official government sources.
Of the 5 registrations, 4 (80%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.